Skip to Content

G 224 (Lithium Carbonate Extended Release 450 mg)

Pill with imprint G 224 is Yellow, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by Glenmark Generics Inc..

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; schizoaffective disorder; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 224

Lithium carbonate extended release 450 mg G 224
Lithium carbonate extended release 450 mg G 224 Front
Lithium carbonate extended release 450 mg G 224 Back
Lithium carbonate extended release 450 mg G 224

Lithium Carbonate Extended Release

Imprint:
G 224
Strength:
450 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Glenmark Generics Inc.
Inactive Ingredients:
sodium alginate
microcrystalline cellulose
ferric oxide yellow
isopropyl alcohol
magnesium silicate
magnesium stearate
sodium starch glycolate type A potato
hypromelloses
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide